Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 106

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 4
Chunk 106
---
 to help patients that suffer from mental health disorders. We strive
to get millions of people out of the cycle of addiction, anxiety, and depression. Not only do we aim to uplift those that are struggling
but also their families, communities, and societies.

Our People

Collectively, our team has vast experience across
the business and pharmaceutical industries. Our Chief Executive Officer, Adi Zuloff-Shani, PhD, is a biomedical research and development
executive with over 25 years of strategic and operational leadership in the healthcare industry, including clinical trials, and a deep
understanding of therapeutics development in heavily regulated environments. Our award-winning advisory board includes professionals such
as Prof. John Krystal. Prof. Krystal is the Robert L. McNeil, Jr. Professor of Translational Research a Professor of Psychiatry, Neuroscience,
and Psychology and Chair of the Department of Psychiatry at the Yale University. He is also Chief of Psychiatry and Behavioral Health
at Yale-New Haven Hospital. He is a graduate of the University of Chicago, Yale University School of Medicine, and the Yale Psychiatry
Residency Training Program. He has published extensively on the neurobiology and treatment of schizophrenia, alcoholism, PTSD, and depression.
Notably, his laboratory discovered the rapid antidepressant effects of ketamine in humans. He is the Director of the NIAAA Center for
the Translational Neuroscience of Alcoholism and the Clinical Neuroscience Division of the VA National Center for PTSD. Prof. Krystal
is a member of the U. S. National Academy of Medicine and a Fellow of the American Association for the Advancement of Science. Currently,
he is co-director of the Neuroscience Forum of the U. S. National Academies of Sciences, Engineering, and Medicine; and editor of Biological
Psychiatry (IF=12.1). He has chaired the NIMH Board of Scientific Counselors and served on the national advisory councils for both NIMH
and NIAAA. Also, he is past president of the American College of Neuropsychopharmacology (ACNP) and International College of Neuropsychopharmacology
(CINP). Prof. Gabriele Fischer, Prof. Christian Schültz, Prof. Wim van den Brink, Prof. Michael Davidson, Prof. Alon Friedman, Prof.
Gal Yadid, Prof. Yossi Tam, Dr. Fatima Cody Stanford and Prof. Henry R. Kranzler are all also part of our outstanding advisory board.

About